Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 3
1975 1
1976 1
1978 1
1979 1
1980 5
1981 5
1982 3
1983 5
1984 4
1985 4
1986 4
1987 4
1988 4
1989 5
1990 2
1991 5
1992 5
1993 3
1994 1
1995 2
1996 2
1997 2
1998 7
1999 3
2000 4
2001 2
2002 2
2003 6
2004 3
2005 4
2006 5
2007 4
2008 3
2009 13
2010 6
2011 14
2012 11
2013 10
2014 9
2015 7
2016 8
2017 8
2018 12
2019 10
2020 12
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

220 results
Results by year
Filters applied: . Clear all
Page 1
Sickle cell trait diagnosis: clinical and social implications.
Naik RP, Haywood C Jr. Naik RP, et al. Hematology Am Soc Hematol Educ Program. 2015;2015(1):160-7. doi: 10.1182/asheducation-2015.1.160. Hematology Am Soc Hematol Educ Program. 2015. PMID: 26637716 Free PMC article. Review.
In 1949, homozygous Hb S or sickle cell disease (SCD) became the first inherited condition identified at the molecular level; however, since then, both SCD and heterozygous Hb S, sickle cell trait (SCT), have endured a long and complicated history. Has …
In 1949, homozygous Hb S or sickle cell disease (SCD) became the first inherited condition identified at the molecular level; …
Sickle Cell Anemia and Its Phenotypes.
Williams TN, Thein SL. Williams TN, et al. Annu Rev Genomics Hum Genet. 2018 Aug 31;19:113-147. doi: 10.1146/annurev-genom-083117-021320. Epub 2018 Apr 11. Annu Rev Genomics Hum Genet. 2018. PMID: 29641911 Review.
In the 100 years since sickle cell anemia (SCA) was first described in the medical literature, studies of its molecular and pathophysiological basis have been at the vanguard of scientific discovery. ...Meanwhile, an unprecedented number of new drugs aimed at both t …
In the 100 years since sickle cell anemia (SCA) was first described in the medical literature, studies of its molecular and pa …
Alpha and beta thalassemia.
Muncie HL Jr, Campbell J. Muncie HL Jr, et al. Am Fam Physician. 2009 Aug 15;80(4):339-44. Am Fam Physician. 2009. PMID: 19678601 Free article. Review.
Imbalances of globin chains cause hemolysis and impair erythropoiesis. Silent carriers of alpha thalassemia and persons with alpha or beta thalassemia trait are asymptomatic and require no treatment. ...
Imbalances of globin chains cause hemolysis and impair erythropoiesis. Silent carriers of alpha thalassemia and persons with alpha or …
The current state of sickle cell trait: implications for reproductive and genetic counseling.
Pecker LH, Naik RP. Pecker LH, et al. Blood. 2018 Nov 29;132(22):2331-2338. doi: 10.1182/blood-2018-06-848705. Blood. 2018. PMID: 30487130 Free PMC article. Review.
Sickle cell trait (SCT) is unique among the carrier states that are identified during newborn screening. Unlike other heterozygous states for rare recessive diseases, SCT is exceedingly prevalent throughout regions of the world, making
Sickle cell trait (SCT) is unique among the carrier states that are identified during newborn screening.
Sickle Cell Disease.
Bender MA. Bender MA. 2003 Sep 15 [updated 2021 Jan 28]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. 2003 Sep 15 [updated 2021 Jan 28]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301551 Free Books & Documents. Review.
All states in the US have included newborn screening for SCD since 2005. ...Carrier detection for common forms of SCD is most commonly accomplished by isoelectric focusing or HPLC. ...
All states in the US have included newborn screening for SCD since 2005. ...Carrier detection for common forms o …
Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.
Naik RP, Smith-Whitley K, Hassell KL, Umeh NI, de Montalembert M, Sahota P, Haywood C Jr, Jenkins J, Lloyd-Puryear MA, Joiner CH, Bonham VL, Kato GJ. Naik RP, et al. Ann Intern Med. 2018 Nov 6;169(9):619-627. doi: 10.7326/M18-1161. Epub 2018 Oct 30. Ann Intern Med. 2018. PMID: 30383109 Free PMC article.
BACKGROUND: Although sickle cell trait (SCT) is largely a benign carrier state, it may increase risk for certain clinical outcomes. ...LIMITATION: Publication bias was possible, and high-quality evidence was scant. CONCLUSION: Sickle cell trait …
BACKGROUND: Although sickle cell trait (SCT) is largely a benign carrier state, it may increase risk for certain clinic …
Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.
Ashley-Koch A, Yang Q, Olney RS. Ashley-Koch A, et al. Am J Epidemiol. 2000 May 1;151(9):839-45. doi: 10.1093/oxfordjournals.aje.a010288. Am J Epidemiol. 2000. PMID: 10791557 Review.
Sickle cell disease is caused by a variant of the beta-globin gene called sickle hemoglobin (Hb S). ...Despite this advantage, individuals with sickle cell disease exhibit significant morbidity and mortality. Symptoms include chronic anemia, acu
Sickle cell disease is caused by a variant of the beta-globin gene called sickle hemoglobin (Hb S). ...Despite this adv
International perspectives on the implementation of reproductive carrier screening.
Delatycki MB, Alkuraya F, Archibald A, Castellani C, Cornel M, Grody WW, Henneman L, Ioannides AS, Kirk E, Laing N, Lucassen A, Massie J, Schuurmans J, Thong MK, van Langen I, Zlotogora J. Delatycki MB, et al. Prenat Diagn. 2020 Feb;40(3):301-310. doi: 10.1002/pd.5611. Epub 2019 Nov 29. Prenat Diagn. 2020. PMID: 31774570 Review.
Reproductive carrier screening started in some countries in the 1970s for hemoglobinopathies and Tay-Sachs disease. ...This review describes screening in Australia, Cyprus, Israel, Italy, Malaysia, the Netherlands, Saudi Arabia, the United Kingd …
Reproductive carrier screening started in some countries in the 1970s for hemoglobinopathies and Tay-Sachs disease. ... …
Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT. Steele C, et al. Am J Hematol. 2019 Jan;94(1):39-45. doi: 10.1002/ajh.25305. Epub 2018 Oct 31. Am J Hematol. 2019. PMID: 30290004 Free PMC article. Clinical Trial.
Sickle cell disease (SCD) is a common, life-threatening genetic disorder that is best managed when diagnosed early by newborn screening. ...In 587 participants, across all study sites, HemoTypeSC had an overall sensitivity of 99.5% and specificity of 9
Sickle cell disease (SCD) is a common, life-threatening genetic disorder that is best managed when diagnosed early by n
Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA.
Zhang J, Li J, Saucier JB, Feng Y, Jiang Y, Sinson J, McCombs AK, Schmitt ES, Peacock S, Chen S, Dai H, Ge X, Wang G, Shaw CA, Mei H, Breman A, Xia F, Yang Y, Purgason A, Pourpak A, Chen Z, Wang X, Wang Y, Kulkarni S, Choy KW, Wapner RJ, Van den Veyver IB, Beaudet A, Parmar S, Wong LJ, Eng CM. Zhang J, et al. Nat Med. 2019 Mar;25(3):439-447. doi: 10.1038/s41591-018-0334-x. Epub 2019 Jan 28. Nat Med. 2019. PMID: 30692697
Current non-invasive prenatal screening is targeted toward the detection of chromosomal abnormalities in the fetus(1,2). ...The initial clinical study demonstrated that this non-invasive test can provide valuable molecular information for the detection of a w …
Current non-invasive prenatal screening is targeted toward the detection of chromosomal abnormalities in the fetus(1,2). ...Th …
220 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page